http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#Head http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#assertion http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#provenance http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#pubinfo http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#assertion http://purl.obolibrary.org/obo/DOID_2349 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_2349 http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01576 http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#association http://www.w3.org/2000/01/rdf-schema#label "Advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma. Agitated states. Patients with a history of drug abuse. Known hypersensitivity or idiosyncrasy to amphetamine. In patients known to be hypersensitive to amphetamine, or other components of dextroamphetamine sulfate extended-release capsules. Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products ( see ADVERSE REACTIONS Patients taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive crisis ( see WARNINGS and Drug Interactions" http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB01576 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#provenance http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#pubinfo http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#sig http://purl.org/nanopub/x/hasSignature MLliaJTAG4ksx1usYvm8Qaf8IoyDdJLlvzE4stw4O2+i+dgQr3EdRSf9Qg7pstn3DPpZ4SyCJftKeshwXlOeh2kiUg73MgFIL7aAPSUWfxJyNHydj+eFoKbvEwSjSUDcMypqAwk45tB/QVGJ6sFU37ua0+e0P+hZ4EKAC9/LfUI= http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g http://purl.org/dc/terms/created 2021-08-23T12:59:08.984+02:00 http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY